MYX 2.67% $4.62 mayne pharma group limited

I did not like CEOs comments regarding others masking why not...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,395 Posts.
    lightbulb Created with Sketch. 266
    I did not like CEOs comments regarding others
    masking why not sell Salisbury Plant . ( International)
    What kind of leadership is that for a Pharmaceutical
    Company. What would that leave Mayne with. Not
    even ownership of an office anywhere. Just a whole
    lot of proven incompetent sales representatives and a
    rented warehouse somewhere distributing products
    belonging to Pharmaceutical Companies at ever
    increasing losses until all the money is gone after selling
    their profitable assets.
    Seriously had they not sold Generics for US $90m
    plus a little they would not have any cash left even
    now. 8 months after sale of Metrics by June end .
    God only knows how much they have spent during
    last two months. The Miami sales conference. Lasting
    long enough to have negatively impacted sales. Besides
    the huge expenses incurred.
    They keep referring to Nextellis as the Flagship. My god
    with a bloody army of sales representatives in 50 states
    and they sold $14.1m gross. This single product has cost
    us nearly $500m so far in shares plus costs then sales
    and marketing. Flagship ! I think we may be on the wrong
    boat. Their cash burn is astronomical
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.